Clinical Trial Update: CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers [Phase 2]

View source ↗

Summary

Phase 2 trial update confirms completion of the CRD007 study evaluating treatment for Duchenne muscular dystrophy and Becker muscular dystrophy (including sympt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy
• Duchenne Muscular Dystrophy

Drugs mentioned

• CRD007

Snippet

Sponsor: RSPR Pharma AB | Conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy | Phase 2 | Status: COMPLETED